PGC1α Plays a Critical Role in TWEAK–Induced Cardiac Dysfunction
Jianru Shi(Brigham and Women's Hospital), Ronglih Liao(Amyloidosis Foundation), Xin Cao(Beijing Tsinghua Chang Gung Hospital), Michael Bauer(Jena University Hospital), Lihe Su(Biogen (United States)), Linda C. Burkly(Biogen (United States)), Yiling Qiu(Brigham and Women's Hospital), Bingbing Jiang(Donghua University), Jian Guan(Ocean University of China), Teresa C. Leone(Cardiovascular Institute of the South), Mohit Jain(University of California San Diego), Daniel P. Kelly(Cardiovascular Institute of the South)
Cited by 33
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
|Journal of Clinical Investigation|2000|1.3k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|942
A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
|Proceedings of the National Academy of Sciences|1999|940